Global Banking & Finance

DECEMBER 2, 2024

By Joanna Plucinska LONDON (Reuters) -AirBaltic is pushing its planned initial public offering back to the first half of 2025 or later as its advisers suggest waiting for improved market conditions in the European sector.

IPO 52

IPO Initial Public Offering IT Business 52

CNBC: Investing

JUNE 9, 2025

Israel-based eToro went public on May 15 , with its initial public offering price at $52 per share, above the high end of its proposed range. " Cantor Fitzgerald initiates coverage at overweight and price target of $84 per share Analyst Brett Knoblauch's target equates to 22% upside.

IPO 65

IPO Trading IT Retail 65

Global Banking & Finance

DECEMBER 6, 2024

LISBON (Reuters) – The three owners of Portugal’s fourth-largest bank Novo Banco have agreed to lift a ban on dividend payouts, paving the way for its potential sale or an initial public offering in 2025, the finance minister was quoted as saying on Friday.

Sale 52

Sale Initial Public Offering Finance Finance 52

Global Banking & Finance

NOVEMBER 25, 2024

MADRID (Reuters) – Private equity investor Blackstone plans to list shares of Spanish gambling company Cirsa in the first half of 2025 in an initial public offering, local newspaper Expansion reported on Monday, citing unidentified market sources. billion)floating between 20% […]

Initial Public Offering 40

Initial Public Offering Shares Private Equity Equities 40

JD Supra: Mergers

MARCH 18, 2025

On 3 March 2025, the Division of Corporation Finance of the Securities and Exchange Commission (the SEC) announced that it is expanding the scope of availability for companies to submit draft registration statements for nonpublic review. In 2017, the SEC. By: K&L Gates LLP

Initial Public Offering 165

Initial Public Offering Corporate Finance Finance Finance 165

Cooley M&A

JANUARY 22, 2025

billion kicking off 2025 with a bang, will the pounds go back on in the new year? Below we take a look at drivers of these dynamics over the past year and offer our predictions for whats to come in 2025. With J&Js announced deal to acquire Intra-Cellular Therapies for $14.6

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

MergersCorp M&A International

MAY 27, 2025

However, 2024 and early 2025 have signaled a re-evaluation and adaptation of the SPAC model, with a renewed focus on quality, transparency, and strategic alignment. Conflicts of Interest: The economic interests of SPAC sponsors may not always align with those of public shareholders, creating potential conflicts of interest.

IPO 52

IPO Mergers and Acquisitions Investors Capital 52